Fosun Pharma Given OK for Hong Kong IPO

Shanghai Fosun Pharma has been given regulatory approval to issue 547 million H shares in a Hong Kong IPO. The transaction is expected to occur in the second quarter. Because the company's Shanghai stock price has slipped lower in the last six months, the offering has also dropped in size from the original announcement: it is now expected in a range between $600 million and $800 million, down from an initial $960 million. More details.... Stock Symbol:  (SHA: 600196) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});